2001
DOI: 10.1677/joe.0.171r005
|View full text |Cite
|
Sign up to set email alerts
|

Stimulation of extracellular signal-regulated kinase by pituitary adenylate cyclase-activating polypeptide in alpha T3-1 gonadotrophs

Abstract: The putative hypophysiotropic factor pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates glycoprotein hormone -subunit ( GSU) gene transcription and secretion in the clonal gonadotroph T3-1 cell line. The specific signalling pathways regulating these actions of PACAP have not been clearly defined. We have examined the possibility that mitogen activated protein kinases (MAPKs) may play a role in mediating the effects of PACAP on T3-1 gonadotrophs. Treatment of T3-1 cells with PACAP (100 nM) or… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
13
0

Year Published

2003
2003
2019
2019

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 24 publications
4
13
0
Order By: Relevance
“…It is now well established that not just cytokine and growth factor receptors but also G protein-coupled receptors can stimulate the MAPK pathway (26). We have, for example, shown that pituitary adenylate cyclase-activating polypeptide can stimulate ERK 1/2 via its G protein-coupled receptor (GPCR), stimulating phospholipase C and PKC (27), and similar effects have been demonstrated for other Gq-coupled receptors such as gonadotrophin-releasing hormone and thyrotrophin-releasing hormone (28,29). Interestingly, it has recently been demonstrated that peptides with receptors primarily working via the cAMP pathway can also activate the PKC pathway and cause activation of MAPK (30).…”
Section: Discussionmentioning
confidence: 99%
“…It is now well established that not just cytokine and growth factor receptors but also G protein-coupled receptors can stimulate the MAPK pathway (26). We have, for example, shown that pituitary adenylate cyclase-activating polypeptide can stimulate ERK 1/2 via its G protein-coupled receptor (GPCR), stimulating phospholipase C and PKC (27), and similar effects have been demonstrated for other Gq-coupled receptors such as gonadotrophin-releasing hormone and thyrotrophin-releasing hormone (28,29). Interestingly, it has recently been demonstrated that peptides with receptors primarily working via the cAMP pathway can also activate the PKC pathway and cause activation of MAPK (30).…”
Section: Discussionmentioning
confidence: 99%
“…In the T3-1 cell line, PACAP continues to stimulate GSU mRNA levels in the presence of PKC depletion (Tsujii et al 1995), pharmacological blockade of calcium entry (Burrin et al 1998) and inhibition of MAPK signalling (Fowkes et al 2001), all evidence that supports a role for the cAMP pathway in mediating the stimulatory transcriptional effects of PACAP on the GSU promoter. In addition, previous studies have shown that the PKA inhibitor, H-89, can attenuate the effect of PACAP on the mouse GSU promoter, albeit when used at concentrations in excess of the K i for this compound (Attardi & Winters 1998).…”
Section: Discussionmentioning
confidence: 99%
“…As such, PAC 1 -R activation results in coupling to both G q and G s to stimulate the DAG/IP/Ca 2+ /PKC pathway and also to adenylyl cyclase, resulting in cAMP production. Most recently, we have shown PACAP to stimulate the activity of a member of the MAPK family, extracellular signal-regulated kinase 1/2 (ERK1/2), in T3-1 cells in a PKC-dependent manner (Fowkes et al 2001). This appears to regulate the proliferative effects of PACAP in these cells.…”
Section: Introductionmentioning
confidence: 99%
“…Following this pretreatment period, the cells were treated for 10 min with serum-free medium alone, 10 nM T 3 or 100 nM T 4 , in the continued presence or absence of 1 mM U0126 or the monoclonal blocking antibody to a V b 3 . Total proteins were then extracted in the presence of phosphatase inhibitors as described previously and ERK activity was measured using the p44/42 MAP Kinase Assay kit (New England Biolabs, Hitchin, UK) as described previously (Fowkes et al 2001). Briefly, active MAPK was immunoprecipitated from cell lysates with an immobilised phosphop44/42 MAP kinase (ERK; Thr202/Tyr204) monoclonal antibody.…”
Section: Total Protein Extractions and Measurement Of Erk Activitymentioning
confidence: 99%